Aquilo Capital Management, LLC
SEC CIK 1591986 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 10% | 3.99M | $8.77M | $4.28M | 9 | 2021-08-30 | 2022-09-22 |
Most active insiders at SPRO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rajavelu Esther | See Remarks | — | $406.8K |
| 2 | Keutzer Timothy | COO | — | $145.2K |
| 3 | Tregoning Kathleen | Dir | — | — |
| 4 | Zack Debra | Chief Medical Off | — | — |
| 5 | Smith Cynthia | Dir | — | — |
| 6 | Jackson Scott Thomas | Dir | — | — |
| 7 | VINK PATRICK V.J.J. | Dir | — | — |
| 8 | Deshpande Milind | Dir | — | — |
| 9 | Pottage John C Jr | Dir | — | — |
| 10 | THOMAS FRANK E | Dir | — | — |
Aquilo Capital Management, LLC made no open-market trades at SPRO in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-09-26 | 2022-09-22 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | S - Sale | $2.25 | -1.90M | 3.99M | -32% | -$4.28M |
| MI | 2022-03-31 | 2022-03-30 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $8.79 | +50.0K | 5.26M | +1.0% | +$439.5K |
| I | 2022-02-23 | 2022-02-18 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $9.24 | +14.8K | 5.16M | +0.3% | +$137.0K |
| I | 2022-02-01 | 2022-01-31 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $11.59 | +125.0K | 5.15M | +2% | +$1.45M |
| I | 2022-01-20 | 2022-01-18 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $12.41 | +48.5K | 5.02M | +1.0% | +$601.7K |
| I | 2022-01-12 | 2022-01-10 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $12.93 | +8,867 | 4.97M | +0.2% | +$114.7K |
| MI | 2022-01-03 | 2021-12-29+ | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $15.42 | +250.5K | 4.79M | +6% | +$3.86M |
| I | 2021-09-10 | 2021-09-09 | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $18.50 | +24.7K | 4.38M | +0.6% | +$457.9K |
| MI | 2021-09-01 | 2021-08-30+ | SPRO | Spero Therapeutics, Inc. | Aquilo Capital Management, LLC | 10% | P - Purchase | $18.43 | +92.7K | 4.36M | +2% | +$1.71M |
Purchase Sale Sale after option exercise All abbreviations